The fragility index and reverse fragility index of FDA investigational device exemption trials in spinal fusion surgery: a systematic review.

MLA

Proal, Joshua D., et al. “The Fragility Index and Reverse Fragility Index of FDA Investigational Device Exemption Trials in Spinal Fusion Surgery: A Systematic Review.” European Spine Journal, vol. 33, no. 7, July 2024, pp. 2594–603. EBSCOhost, https://doi.org/10.1007/s00586-024-08317-3.

APA

Proal, J. D., Moon, A. S., & Kwon, B. (2024). The fragility index and reverse fragility index of FDA investigational device exemption trials in spinal fusion surgery: a systematic review. European Spine Journal, 33(7), 2594–2603. https://doi.org/10.1007/s00586-024-08317-3

Chicago

Proal, Joshua D., Andrew S. Moon, and Brian Kwon. 2024. “The Fragility Index and Reverse Fragility Index of FDA Investigational Device Exemption Trials in Spinal Fusion Surgery: A Systematic Review.” European Spine Journal 33 (7): 2594–2603. doi:10.1007/s00586-024-08317-3.